Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Rui Bi Da (rezivertinib)
i
Other names:
BPI-7711, BPI 7711, BPI-7711 capsule
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Beta Pharma, CSPC Pharma
Drug class:
EGFR antagonist
Related drugs:
‹
CKD-702 (6)
SCT200 (4)
CPGJ-602 (3)
MCLA-158 (2)
BTG-002814 (0)
cetuximab biosimilar (CDP-1) (0)
KL 140 (cetuximab biosimilar) (0)
CKD-702 (6)
SCT200 (4)
CPGJ-602 (3)
MCLA-158 (2)
BTG-002814 (0)
cetuximab biosimilar (CDP-1) (0)
KL 140 (cetuximab biosimilar) (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
rezivertinib
Sensitive: C3 – Early Trials
rezivertinib
Sensitive
:
C3
rezivertinib
Sensitive: C3 – Early Trials
rezivertinib
Sensitive
:
C3
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
rezivertinib
Sensitive: C3 – Early Trials
rezivertinib
Sensitive
:
C3
rezivertinib
Sensitive: C3 – Early Trials
rezivertinib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login